Christmas and New Year Holidays 2021 Notification
Dear Business Partners! Our office will be closed from 24.12.2021 to 02.01.2022 on account of Christmas and New Year holidays. We thank you for your
The infectious respiratory disease COVID-19, caused by the novel Coronavirus SARS-CoV-2, is spreading all over the globe with an alarming speed, and has turned into a pandemic ever since its first appearance in December 2019.
The medical diagnosis of COVID-19 is challenging, since its symptoms are highly variable and can range from asymptomatic condition to flu-like or even life-threatening symptoms like respiratory distress.
Therefore, the WHO recommends screening for the COVID-19 virus via nucleic acid amplification tests, such as RT-PCR.
The Convergys®
POC RT-PCR COVID-19 Testing Platform
Intended use:
Our Testing Platform integrates WHO endorsed RT-PCR methodology into a convenient and easy-to-use format. The pre-filled, single-use cartridges take care of the complete patient sample processing, including RNA extraction, purification and RT-PCR amplification; all within 90 minutes.
The Convergys® POC RT-PCR COVID-19 Testing Platform directly detects SARS-CoV-2 genetic material.
Discover established Convergys® range of Hematology, Electrolyte Analysis, Blood Gases, Urinalysis and Biochemistry.
The élégance® Glucometer Range offers you and your healthcare providers a comfortable, precise and extremely reliable way to manage your diabetes.
With just 0.5 μl sample volume and a 5 second reading time our elegance series will make your blood glucose monitoring experience as comfortable and as painless as possible.
Dear Business Partners! Our office will be closed from 24.12.2021 to 02.01.2022 on account of Christmas and New Year holidays. We thank you for your
Our office will be closed for New Year holidays from 30.01.2020 and we will resume our regular working hours from 04.01.2021. We are looking forward
This rapid chromatographic immunoassay detects the Nucleocapsid protein of SARS-CoV-2, the pathogen causing the COVID-19 disease. The test kit works with nasopharyngeal patient swabs and
Convergent Technologies is an emerging leader in the field of Integrated Healthcare Solutions. We strive to provide innovative and cost-effective healthcare solutions enabling people live healthier lives.
Our state-of-the-art diagnostic systems concentrate on early detection, targeted screening, evaluation and monitoring of diseases.
Convergent Technologies GmbH & Co. KG
Ringstrasse 14
35091 Coelbe, Germany
Tel: +49 6421 88699-48
Fax: +49 6421 88699-58
© Convergent Technologies. All rights reserved.